RxDoctor Payments Data

Stephen Krzeminski, DO

Facial Plastic Surgery · Granbury, TXNPI 1992783393

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.2% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Stryker at 47.8% of the total. That places this record below the midpoint for facial plastic surgery clinicians in TX, where the typical reported total is $1,323.

$1,106in general payments, 2019–2025

Across 43 payments — averaging $25.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$529
  • Sanofi$194
  • Optinose US, Inc.$125
  • Smith+Nephew$66
  • GSK$57
  • Sanofi-aventis U.S. LLC$53
  • plus $82 from 5 others

What the payments were for

  • Food & beverage$1,05395%
  • Education$535%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,106 in reported general payments places this provider in the 45th percentile of 42 facial plastic surgery providers in Texas.

See all facial plastic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$240,183
Medicare patients
467
Services billed
5,511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin24$768
Pantoprazole Sodium113$656
Ipratropium Bromide22$584
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav50$562
Azelastine Hcl32$546
Glycopyrrolate26$410
Methylprednisolone70$408
Mometasone Furoate18$402
Triamcinolone Acetonide14$377
Cephalexin41$357
Doxycycline Hyclate25$320
Levofloxacin39$200
Prednisone28$127
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen47$116
Azithromycin29$94

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Granbury

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →